Clinical Trials on Peritoneal Neoplasm in Norway

Total 1726 results

Galderma R&D

Completed

PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin Cancer

Warts | Actinic Keratosis | Basal Cell Carcinoma | Squamous Cell Carcinoma | Bowens Disease

Denmark, Germany, Norway, Sweden, United Kingdom
University of Dublin, Trinity College
Karolinska Institutet; University of Oxford; Trinity St. James's Cancer Institute

Not yet recruiting

Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial (SARONG-II)

Gastric Cancer | Esophageal Cancer

Norway, Sweden, Ireland, Italy, Germany
BerGenBio ASA
Merck Sharp & Dohme LLC

Completed

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced NSCLC

Lung Cancer Metastatic | Adenocarcinoma of Lung | NSCLC Stage IV

United States, Spain, United Kingdom, Norway
AstraZeneca

Completed

Phase I Study in Patients With Solid Tumours

Neoplasms

France, United Kingdom, Netherlands, Norway
Oslo University Hospital
University of Oslo; University Hospital of North Norway; Norwegian University... and other collaborators

Completed

Prediction and Secondary Prevention of Fractures (NOFRACTsub)

Hip Fractures | Ankle Fractures | Osteoporotic Fractures | Humeral Fractures, Proximal | Vertebral Compression Fractures | Wrist Fractures

Norway
European Myeloma Network
Sanofi; Amgen; EMN Research Italy

Active, not recruiting

Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL) (IsKia)

Multiple Myeloma

Czechia, Germany, Greece, Italy, Netherlands, Norway, Spain
Clavis Pharma
Syneos Health; Theradex

Completed

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Acute Myeloid Leukemia

United States, Norway, Germany, France
University of Aarhus
Nordic Lymphoma Group

Completed

A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT

Peripheral T-Cell Lymphoma

Norway, Finland, Denmark
Haukeland University Hospital
Pfizer; AstraZeneca; Helse Vest

Active, not recruiting

PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial (PETREMAC)

Breast Cancer

Norway
Melanoma Institute Australia
Bristol-Myers Squibb

Recruiting

Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) (ABC-X)

Melanoma Stage Iv

Australia, Norway
University of Oxford
National Institute for Health Research, United Kingdom; European Commission; Oxford... and other collaborators

Terminated

A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS) (MEMOS)

Osteosarcoma

United Kingdom, Germany, Italy, Netherlands, Norway
San Raffaele University
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Ospedale... and other collaborators

Recruiting

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer (DEMETRA)

Colorectal Cancer | Diet Habit | Risk Reduction | Early Onset Colorectal Cancer

United States, Finland, Germany, Italy, Norway, Spain
Mendus
Amsterdam UMC, location VUmc

Active, not recruiting

Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia (ADVANCE-II)

Acute Myeloid Leukemia in Remission

Norway, Netherlands, Sweden, Finland, Germany
University Ghent
University Hospital, Geneva

Active, not recruiting

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (STORM)

Prostate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic Cancer

Norway, Spain, Belgium, Switzerland, Australia, Italy
Karolinska Institutet
Medical University of Vienna; Oslo University Hospital; Sahlgrenska University... and other collaborators

Terminated

Randomized Clinical Study Assessing Haplo vs. URD in AML

Acute Myeloid Leukemia

Canada, Austria, Sweden, Russian Federation, Norway
Norwegian University of Science and Technology
St. Olavs Hospital; Helse Midt-Norge

Active, not recruiting

MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway

Pathologic Processes | Cardiovascular Diseases | Vascular Diseases | Stroke | Cerebrovascular Disorders | Nervous System Diseases | Brain Ischemia | Cardiovascular Risk Factor | Central Nervous System Lymphoma

Norway
Region Örebro County
Helsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaborators

Recruiting

Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients (IMPORTANT)

Quality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older Patients

Sweden, Finland, Greece, Italy, Norway, Spain
Tesaro, Inc.
European Network of Gynaecological Oncological Trial Groups (ENGOT)

Active, not recruiting

A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (FIRST)

Ovarian Neoplasms | Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma

United States, Netherlands, Spain, Finland, Italy, Poland, Belgium, Canada, France, Germany, Romania, Ukraine, Norway, United Kingdom, Israel, Greece, Denmark, Belarus, Czechia
The Netherlands Cancer Institute

Unknown

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas (DOREMY)

Myxoid Liposarcoma of Soft Tissue

Netherlands, United Kingdom, Norway, United States, Denmark
Helse Stavanger HF
King's College London; Lund University

Completed

Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB) (MEMPDD)

Dementia With Lewy Bodies | Dementia Associated With Parkinson's Disease

United Kingdom, Norway, Sweden
AGO Study Group
GERCOR - Multidisciplinary Oncology Cooperative Group; Nordic Society of Gynaecological...

Completed

Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer (AGO-OVAR9)

Ovarian Cancer | Fallopian Tube Cancer

Norway, Germany, France, Denmark
European Organisation for Research and Treatment...

Active, not recruiting

Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma (INNOVATION)

Malignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein Overexpression

Spain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
Prof. Christina Peters
Amgen

Terminated

ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT

Minimal Residual Disease | ALL, Childhood

Norway, Spain, Denmark, Austria, Belgium, Czechia, France, Italy, Poland, Slovakia
Scandinavian Sarcoma Group
GlaxoSmithKline

Completed

Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (PAGIST)

Gastrointestinal Stromal Tumors

Norway, Denmark, Finland, Germany, Sweden
Sanofi

Active, not recruiting

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Neoplasm Malignant

Korea, Republic of, Spain, Czechia, United States, Norway
St. Olavs Hospital
Odense University Hospital; Karolinska University Hospital; Turku University... and other collaborators

Recruiting

Supramarginal Resection in Glioblastoma

Glioblastoma

Norway, Sweden, Finland, Denmark, Austria
European Organisation for Research and Treatment...

Completed

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

Cervical Cancer

Norway, Germany, United Kingdom, Sweden, Austria, France, Netherlands
Cellphire Therapeutics, Inc.
Department of Health and Human Services

Terminated

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Myelodysplastic Syndromes | Myeloproliferative Disorders | Thrombocytopenia | Hematologic Malignancy | Bone Marrow Aplasia | Platelet Refractoriness

United States, Israel, Norway
Jeanette Lundin

Recruiting

A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL) (IbruOnOff)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

Sweden, Norway
Nutricia Research

Completed

Protein Intake in Patients With Colorectal or Lung Cancer When Receiving a Nutritional Supplement (PROTEOS)

Colorectal Cancer | Lung Cancer

Norway, Netherlands, Belgium, Lithuania, Estonia, Poland, Portugal
Fujifilm Medical Systems USA, Inc.
International HealthCare, LLC

Completed

Fujifilm Feature Comparison Reader Study to Compare Old vs New Processing

Breast Cancer

United States
Norwegian University of Science and Technology
University College, London; St. Olavs Hospital; Fondazione I.R.C.C.S. Istituto... and other collaborators

Recruiting

Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache (BASIC)

Cluster Headache

Norway, Germany, Italy, Spain, United Kingdom
Radboud University Medical Center
Johns Hopkins University; University Health Network, Toronto; Medical University... and other collaborators

Completed

Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach (PCa-MAP)

Prostate Cancer

United States, Austria, Belgium, Canada, Germany, Netherlands, Norway, United Kingdom
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Metformin in Pregnant PCOS Women (PregMet)

Polycystic Ovary Syndrome

Norway
CHDI Foundation, Inc.

Completed

Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers (LONGPDE10)

Huntington's Disease

Sweden, Denmark, Netherlands, Norway
CHDI Foundation, Inc.

Completed

[PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET. (PEARL-HD)

Huntington's Disease

Sweden, Denmark, Netherlands, Norway
Sven Löffeler
Oslo University Hospital; Klinbeforsk

Recruiting

Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer (GrandP/SPCG19)

Prostate Cancer

Norway, Denmark, Finland
Lytix Biopharma AS
Laboratory Corporation of America; OWL

Active, not recruiting

Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma (ATLAS-IT-05)

Advanced Melanoma

United States, Spain, France, Norway
Nordic Myeloma Study Group
Nordic Cancer Union

Completed

Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month

Multiple Myeloma

Denmark, Norway, Sweden
European Infant Neuroblastoma Study Group - 1999

Completed

Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma

Neuroblastoma

Switzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
Aarhus University Hospital
Danish Comprehensive Cancer Center; Nordic Cancer Union; The regions medicine-...

Not yet recruiting

NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer

Anal Cancer

Norway, Finland, Denmark, Sweden
European Infant Neuroblastoma Study Group - 1999

Completed

Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.

Neuroblastoma

Switzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
Erasmus Medical Center
Dutch Cancer Society; Dutch Pancreatic Cancer Group

Recruiting

Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer (PREOPANC-3)

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Resectable Pancreatic Adenocarcinoma

Netherlands, Sweden, Norway
Genentech, Inc.

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

Spain, Australia, Denmark, Norway
Norwegian University of Science and Technology

Completed

Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia (NordCML007)

Leukemia, Myeloid, Chronic-Phase

Sweden, Finland, Norway
Norwegian University of Science and Technology
Karolinska University Hospital; Oslo University Hospital; University Hospital... and other collaborators

Recruiting

Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer (TRIPLEX)

Small-cell Lung Cancer

Netherlands, Norway, Sweden, Estonia, Iceland
European Infant Neuroblastoma Study Group - 1999

Completed

Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma

Neuroblastoma

Switzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
Nykode Therapeutics ASA
Roche Pharma AG; Vaccibody AS

Completed

Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer

Cervical Cancer | Cervix Cancer

Belgium, Germany, Bulgaria, Czechia, Norway, Poland
European Infant Neuroblastoma Study Group - 1999

Completed

Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma

Neuroblastoma

Switzerland, Denmark, Spain, United Kingdom, Belgium, France, Austria, Italy, Norway, Portugal, Sweden
Melanoma and Skin Cancer Trials Limited
University of Oxford; Trans Tasman Radiation Oncology Group

Active, not recruiting

Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma (WBRTMel)

Metastatic Melanoma

Norway, Australia, United Kingdom

Clinical Trials on Peritoneal Neoplasm in Norway

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations